A randomized, double-blind, parallel controlled trial for Zhizhu prescription in the treatment of slow transit constipation

The Affiliated Hospital of Qingdao University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patient meets the diagnostic criteria of Rome IV and the diagnosis of deficiency syndrome of traditional Chinese medicine;
•(2) Aged 18 to 80 years old (women of childbearing age need to take contraceptive measures during the study period);
•(3) The patient can cooperate with the treatment, and the doctor can obtain the patient's detailed history and fill in the score scale of the history;
•(4) the interval between the end time of the last other treatment and treatment of this study is more than 1 week;
•(5) patients agree not to use any food or drugs that affect gastrointestinal peristalsis during treatment;
•(6) patients agree to accept the treatment process and sign an informed consent form.

•(1) women during pregnancy and lactation;
•(2) those who are allergic to the drugs in this study;
•(3) Patients with outlet obstruction constipation and irritable bowel syndrome;
•(4) Those who have taken other defecation promoting drugs within 1 week before treatment or during treatment;
•(5) Patients with serious primary diseases such as cardiovascular,urinary, hematopoietic, endocrine system and malignant tumors, and patients with a history of alcohol and drug abuse and psychosis;
•(6) Patients with intestinal stenosis caused by organic lesions (such as Crohn's disease, colonic polyps and intestinal tuberculosis) or those with a history of abdominal surgery;
•(7) Fail to take medicine according to the regulation, cause curative effect cannot judge, or because the life environment often changes and other factors easily cause the loss of visitors.

发起方